Report cover image

Clinical Trials Scorecard for Clinical Trial Investigations in 2022

Publisher GlobalData
Published Mar 15, 2023
Length 57 Pages
SKU # GBDT17955404

Description

Clinical Trials Scorecard for Clinical Trial Investigations in 2022


Summary
This report provides an overview of global clinical trials with a start date between January 1, 2022, and December 31, 2022.

Scope
  • The clinical trials data used for these analyses were extracted from GlobalData’s Clinical Trials Database. The data included clinical trials with a start date between January 1, 2022 and December 31, 2022, which were captured in the database as of February 14, 2023. The trials were analyzed and segmented by phase, single versus multinational trials, geography, sponsor type (industry versus non-industry), therapy area, indication, top sponsors, molecule type, and top drug trials.
Reasons to Buy
  • Trends of 2022 trial landscape
  • Comparison to 2021 trial landscape
  • Can view top therapy areas,indications, geographies and sponsors for 2022 trials
  • Designated focus on completed and terminated trials for 2022
  • Spotlight on COVID-19

Table of Contents

57 Pages
Executive Summary
Introduction
Global Clinical Trial Landscape in 2022
Completed Trials in 2022
Clinical Trial Terminations in 2022
Spotlight on COVID-19 Clinical Trials for 2022
Key Findings
Appendix
List of Figures
Figures 1 and 2: Clinical trials by sponsor type, status and initiation/completion
Figures 3 and 4: Clinical trials, by phase and sponsor type
Figure 5: Single country and multinational trials
Figure 6: Clinical trials regions, by phase
Figure 7: Clinical trials regions, by phase and distribution
Figure 8: Clinical trials in top countries, by phase
Figure 9: Clinical trials in top countries, by phase and distribution
Figure 10: Clinical trials top therapy areas, by phase
Figure 11: Clinical trials top therapy areas, by phase and distribution
Figure 12: Pivotal/registration clinical trials top therapy areas, by phase
Figure 13: Clinical trials top indications, by phase
Figure 14: Clinical trials top indications, by phase and distribution
Figure 15: Pivotal/registration clinical trials top indications, by phase
Figure 16: Clinical trials top industry sponsors, by phase
Figure 17: Clinical trials top non-industry sponsors, by phase
Figure 18: Pivotal/registration clinical trials top industry sponsors, by phase
Figure 19: Completed trials endpoint status, by sponsor type
Figures 20 and 21: Completed trials endpoint status, by sponsor type and phase
Figure 22: Pivotal/registration industry-sponsored trials endpoint status, by phase
Figure 23: Completed clinical trials top sponsors, by phase
Figure 24: Top completed drugs, by clinical trial count
Figures 25 and 26: Terminated trials, by phase and reason
Figure 27: Terminated clinical trials top therapy areas, by phase
Figure 28: Terminated clinical trials top indications, by phase
Figure 29: Terminated clinical trials for sponsors, by phase
Figure 30: Clinical trials for COVID-19, by status and sponsor type
Figure 31: Clinical trials for COVID-19, by phase
Figure 32: Clinical trials for COVID-19, by top industry sponsors
Figure 33: Clinical trials for COVID-19, by top non-industry sponsors
Figures 34 and 35: Clinical trials for COVID-19, by molecule type and phase
Figures 36 and 37: Virtual trial components

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us